Find Heart Cardiovascular Diseases Test Kit, Myoglobin Test Kit, Troponin I Test Kit on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Cardiovascular > Cardiovascular diseases Myoglobin test kit

Cardiovascular diseases Myoglobin test kit

Cardiovascular diseases Myoglobin test kit

    Payment Type: L/C,T/T,Western Union
    Terms of Trade: FOB,CFR,CIF,EXW,FCA,CPT,CIP
    Delivery Time: 5 Days
    Packaging: box/carton
    Transportation: Ocean,Air
    Port: Hongkong,Shanghai

Basic Info

Model No.: heart cardiovascular diseases

Product Description

Myoglobin test kit (classified as Cardiovascular disease detection)


[Product description]: the product can be used with Bioda immune detector to quantitatively detect myoglobin in human whole blood, serum and plasma, and it can provide reference for clinical diagnosis of myocardial infarction.

Myoglobin mainly exists in striated muscle (myocardium and skeletal muscle) cells and plays an important role in the membrane oxidation. As it is a kind of small molecular substance (relative molecular weight: 17,000-18,000), Mb is the first biomarker to enter the blood when myocardial cells are damaged, of which diffusion into the blood is faster than CK-MB mass or cTnI/cTnT. However, due to the expression of myoglobin in skeletal muscle, a large number of myoglobin can also be released in case of skeletal muscle injury, which is free from myocardial specificity. Myoglobin as a small molecular substance will flow into the blood rapidly in acute myocardial infarction (AMI). Therefore, the level of serum myoglobin can be dynamically detected twice for early diagnosis of AMI within 1.5-6 h after AMI. If the second detection value is significantly higher than the first one, the result is of very high positive prediction value; if there is no difference between the two dynamic detection values, the result is of good negative prediction value, excluding the possibility of AMI.


[Reaction time]: 12 min


[Detection range]: 10-1,000ng/ml


[Clinical significance]: diagnosis of myocardial injury and acute myocardial infarction (AMI)


[Applicable departments]: Outpatient Department, Emergency Department, Cardiology Department, Thoracic Surgery Department, Ambulance, Ward, ICU, Geriatrics Department


[Interpretation method]:

ng/ml

Detection results (ng / ml)


Description

Myoglobin70


Negative

Myoglobin70

Myocardial injury and acute myocardial infarction (AMI)



ZSL MED

 

Zhenjiang SL Electronic Technology Co., Ltd. was founded in 2013, with a registered capital of 100 million yuan, is located in the beautiful historical and cultural city of Zhenjiang city, the company is headquartered in China small and Medium-sized enterprise information industry Park, a number of RESEARCH and development and production bases are located in Zhenjiang, Nanjing and Other places.


Company is a leading Chinese Internet portable and medical equipment trade and a body comprehensive enterprise, main products and services cover portable medical equipment, special background and the APP, the database construction, database management and application, and with Tsinghua university, Shanghai yan chai hospital more than domestic top medical research institutions and units established a strategic cooperative partnership.


Company team members committed to accurate early cancer screening + intelligent slow disease supervision, independent research and development of ecg detecting system, screening system, such as the core technology, independent research and development the APP is used to collect a lot of slow heart monitoring, tumor detection map data and regional people health, the future through data technology solutions for mass slow disease, improve the health level.


Since its establishment, the company has persisted in making breakthroughs and developing in innovation, and applied for dozens of patents. It has been successively awarded the honorary titles of Jiangsu High-tech Enterprise, Jiangsu Private Science and Technology Enterprise, Innovation and Entrepreneurship Advanced Unit and so on. The products are widely used in hospitals at all levels, physical examination, public welfare for the aged and grass-roots medical institutions.


In the future, the company will continue to take early health screening as its development strategic goal, and strive to become a leading large technology complex industrial group in the health screening industry, so as to provide and create more high-quality products and services for customers and lead a more harmonious and healthy society.

Company Info

  • Company Name: ZSL MED
  • Representative: CHEN ZUBIN
  • Product/Service: Immunology Analyzer , Chemistry Analyzer , Hematology Analyzer , Urine Analyzer , SARS COV-2 POCT Analyzer , HbA1c Analyzer
  • Capital (Million US $): 100 Million RMB
  • Year Established: 2013
  • Total Annual Sales Volume (Million US $): US$1 Million - US$2.5 Million
  • Export Percentage: 31% - 40%
  • Total Annual Purchase Volume (Million US $): US$1 Million - US$2.5 Million
  • No. of Production Lines: above 20
  • No. of R&D Staff: 11 -20 People
  • No. of QC Staff: 5 -10 People
  • OEM Services Provided: yes
  • Factory Size (Sq.meters): 1,000-3,000 square meters
  • Factory Location: Building 3, 303, Yushan rd, Jingkou Dist. Zhenjiang city, Jiangsu,China
  • Contact Person: Mr. Richard
  • Tel: 86-755-23253102
Email to this supplier
  • *Subject:
  • To:

  • *Messages:
    Your message must be between 20-8000 characters